ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.99
0.88%
US Tech 100
20,892.40
1.80%
S&P 500
6,006.97
1.17%
US Dollar vs CAD
1.44525
0.40%
Bitcoin
105,142.27
5.13%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Caribou Biosciences Inc (CRBU)

  7. Caribou Biosciences Inc (CRBU) News

Caribou Biosciences Inc

Caribou Biosciences Inc (CRBU)

Amd Commo Exagr
1.52
-0.02
( -1.30% )
Updated: 12:57:47
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

CRBU News

Official News Only

Form 8-K - Current report
Edgar (US Regulatory)
January 13 2025
CRBU (-1.30%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 10 2025
CRBU (-1.30%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
January 10 2025
CRBU (-1.30%)

Form 8-K - Current report
Edgar (US Regulatory)
January 02 2025
CRBU (-1.30%)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Edgar (US Regulatory)
December 06 2024
CRBU (-1.30%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
November 22 2024
CRBU (-1.30%)

CRBU Discussion

View Posts
Monksdream Monksdream 2 weeks ago
CRBU. Under $2
👍️0
Monksdream Monksdream 4 weeks ago
CRBU under $2
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
CRBU READY TO BEAST
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
CRBU...NEW SCAN JUST GAVE ME THIS BIO
👍️0
Monksdream Monksdream 3 months ago
CRBU under $3
👍️0
Monksdream Monksdream 3 months ago
CRBU under $2
👍️0
Monksdream Monksdream 5 months ago
CRBU under $3
👍️0
Monksdream Monksdream 6 months ago
CRBU under $3
👍️0
jondoeuk jondoeuk 6 months ago
Earlier this year development of the lead CAR-NK programme, CB-020, was stopped, and now they are out of CAR-NK altogether. They disclosed it in an SEC filing and outlined a 12% workforce reduction https://www.sec.gov/Archives/edgar/data/1619856/000161985624000054/crbu-20240716.htm

This should extend their cash runway by at least six months, into the second half of 2026.
👍️0
Monksdream Monksdream 6 months ago
CRBU under $3
👍️0
Monksdream Monksdream 7 months ago
CRBU new 52 week low
👍️0
Monksdream Monksdream 7 months ago
CRBU new 52 week low
👍️0
NY1972 NY1972 7 months ago
Without engaging macrophage long term, CART and other ACT will have persistence issue as regulatory lymphocytes and TAM recoup. AFMD has the best approach with ICE engaging a few B CBNK cells for start and engaging endogenous NK and M in the maintenance phase
👍️0
Diego Rivas Diego Rivas 7 months ago
Any good news in here comming?
👍️0
jondoeuk jondoeuk 7 months ago
Among patients with four or more matching HLA alleles, mPFS was 14.4 months, versus 2.8 months in patients with three or fewer matches. But this is based on a retrospective analysis, so they will need to prove the theory prospectively. It was better in LBCL, with mPFS not reached, versus 2.8 months. Also, some improvement in the now-selected dose, 80 million CAR-T cells.
👍️0
jondoeuk jondoeuk 7 months ago
The BCMA-targeted space is already crowded enough and off-target toxicities, including agranulocytosis* could be a problem for its anti-CLL-1 CAR.

* CLL-1 is also highly expressed on almost all granulocytes and monocytes and on parts of myeloid progenitors in the normal bone marrow and peripheral blood.
👍️0
Monksdream Monksdream 7 months ago
CRBU new 52 week low
👍️0
stocksrising stocksrising 7 months ago
Yep, not a positive trend hence sub $3’s…fortunately other trials for varied indications could save company…
👍️0
jondoeuk jondoeuk 8 months ago
It gets worse. The updated (CB-010) data shows that the ORR (including CR rate) has fallen, so has the mDOR, the six-month PFS is poor and the pivotal trial has been delayed until H2 2025 following a new HLA partial matching strategy. The latter completely alters (in a bad way) the commercial strategy for an allo CAR-T product. They now need thirteen different off-the-shelf batches to be able to cater to ~90% of patients based on an ideal HLA match.
👍️ 1
Monksdream Monksdream 8 months ago
CRBU new 52 week low
👍️0
Monksdream Monksdream 8 months ago
CRBU new 52 week low
👍️0
Monksdream Monksdream 9 months ago
CRBU under $5
👍️0
stocksrising stocksrising 10 months ago
It seemed like they were running on all positive cylinders, but must have blown a gasket at current Conference/ Fireside???
👍️0
Monksdream Monksdream 1 year ago
CRBU new 52 week low
👍️0
jondoeuk jondoeuk 2 years ago
Yes, with both drugs still in development. As for CRBU, they gave an update (plus public offering) https://finance.yahoo.com/news/caribou-biosciences-reports-positive-clinical-200100822.html https://investor.cariboubio.com/static-files/d818ed1a-aea2-41c1-84ea-bd05a4276cbb

Personally, there seem to be red flags, such as no expansion/persistence data. I know they give huge amounts of LD chemo, higher (I think) than anyone else, which could be generating responses, explaining why there is no dose response.
👍️0
trueblue trueblue 2 years ago
.
👍️0
trueblue trueblue 2 years ago
$23.00 price target! Now that is a good start!! Glad I loaded up! Jmo
👍️0
NY1972 NY1972 2 years ago
Didn't they buy TRIL? Just gambling with billions from US government.
👍️0
jondoeuk jondoeuk 2 years ago
PFE is very selective in who they fund https://finance.yahoo.com/news/caribou-biosciences-announces-25-million-120000433.html
👍️0
trueblue trueblue 2 years ago
Great day in my accounts again! Really liking my CRBU shares! Jmo holding for the long haul!!
👍️0
Monksdream Monksdream 2 years ago
CRBU now No 9 on the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
trueblue trueblue 2 years ago
Added to my existing shares today, I bought shares months ago. I like Crbu a crisper company! Looks like Pfizer does also! Jmo
👍️0
Stockexpertpro Stockexpertpro 2 years ago
CRBU Loss 108 Million Dollars Company only has preclinical and phase 1 in its pipeline company is Years away from having anything if ever did a stock offering at 5.33$ for 25 Million thats only 1 QTR Cash burn for this company Sell the News https://www.cariboubio.com/pipeline/
👍️0
TheFinalCD TheFinalCD 2 years ago
CRBU= JUST WOW

https://finviz.com/quote.ashx?t=CRBU&ty=c&ta=1&p=d
👍️0
Monksdream Monksdream 2 years ago
CRBU No 1 on the early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0

Your Recent History

NASDAQ
CRBU
Caribou Biosciences
BIT
NSCIT5354658
Intesa Sanpaolo
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads